Insiders trading at Theravance Biopharma Inc

Over the last 10 years, insiders at Theravance Biopharma Inc have traded over $11,583,559 worth of Theravance Biopharma Inc stock and bought 1,509,589 units worth $29,986,811,853,500 . The most active insiders traders include Plc Gsk, Inc. Innoviva,, and Deepika Pakianathan. On average, Theravance Biopharma Inc executives and independent directors trade stock every 57 days with the average trade being worth of $122,163. The most recent stock trade was executed by Rhonda Farnum on 20 February 2024, trading 1,254 units of TBPH stock currently worth $10,922.